Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
Table 2
Expression ratio of WT to ΔGAG TOR1A in lymphoblasts from MC and NMC.
Lymphoblasts
RNA cDNA samples
Samples WT/ΔGAG
Phenotype
Detected allele
MCp ± S.D
ΔCp
Corrected ΔCp
Fold expression
1
MC
WT
27.64 ± 0.22
0.56
0.70
2−0.70
ΔGAG
27.18 ± 0.13
2
MC
WT
24.71 ± 0.08
0.38
0.52
2−0.52
ΔGAG
24.33 ± 0.16
3
MC
WT
24.87 ± 0.08
0.21
0.35
2−0.35
ΔGAG
24.66 ± 0.06
4
MC
WT
25.87 ± 0.15
0.36
0.50
2−0.50
ΔGAG
25.51 ± 0.25
5
MC
WT
27.93 ± 0.13
0.07
0.21
2−0.21
ΔGAG
27.87 ± 0.29
6
NMC
WT
26.58 ± 0.16
0.39
0.53
2−0.53
ΔGAG
26.19 ± 0.04
7
NMC
WT
24.8 ± 0.08
0.14
0.28
2−0.28
ΔGAG
24.67 ± 0.41
8
NMC
WT
29.79 ± 0.17
0.31
0.45
2−0.45
ΔGAG
29.49 ± 0.33
9
NMC
WT
28.53 ± 0.21
0.44
0.58
2−0.58
ΔGAG
28.09 ± 0.35
10
NMC
WT
26.93 ± 0.10
0.29
0.43
2−0.43
ΔGAG
26.63 ± 0.19
Genomic DNA
WT
26.06 ± 0.14
−0.14
0
20
WT/ΔGAG
ΔGAG
26.2 ± 0.48
WT/WT: homozygous for the normal allele; WT/ΔGAG-TOR1A: carrier heterozygous for the mutant allele; AS-F, ASWT-R, ASΔE-R: allelic-specific set of primers (Figure 1); MC: manifesting carrier; NMC: non-manifesting carrier; MCp ± S.D: mean Cp values of triplicates for each reaction; ΔCp: MCp for WT minus MCp for mutant allele primer for each sample; corrected ΔCp: mean ΔCp of each RNA sample minus ΔCp of heterozygous genomic DNA sample.